Australia markets closed

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
2.4000+0.0100 (+0.42%)
At close: 04:00PM EDT
2.5200 +0.12 (+5.00%)
After hours: 07:15PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts6775
Avg. Estimate-0.17-0.17-0.6-0.74
Low estimate-0.22-0.21-0.69-0.84
High estimate-0.14-0.14-0.55-0.62
Year ago EPS-0.1-0.17-0.51-0.6
Revenue estimateCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
No. of analysts9897
Avg. Estimate7.95M8.24M33.6M48.61M
Low estimate5.1M5.1M27.48M22M
High estimate10.62M11.76M40M94M
Year ago sales11.84M9.18M38.02M33.6M
Sales growth (year/est)-32.90%-10.20%-11.60%44.70%
Earnings history29/09/202330/12/202330/03/202429/06/2024
Est. EPS-0.13-0.13-0.17-0.14
Actual EPS-0.1-0.17-0.14-0.13
Difference0.03-0.040.030.01
Surprise %23.10%-30.80%17.60%7.10%
EPS trendCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Current estimate-0.17-0.17-0.6-0.74
7 days ago-0.17-0.17-0.6-0.74
30 days ago-0.16-0.17-0.6-0.73
60 days ago-0.14-0.15-0.57-0.62
90 days ago-0.14-0.15-0.57-0.62
EPS revisionsCurrent qtr. (Sep 2024)Next qtr. (Dec 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/A11N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesABCLIndustrySector(s)S&P 500
Current qtr.-70.00%N/AN/AN/A
Next qtr.N/AN/AN/AN/A
Current year-17.60%N/AN/AN/A
Next year-23.30%N/AN/AN/A
Next 5 years (per annum)10.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A